These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34216350)

  • 1. L-carnitine protects DNA oxidative damage induced by phenylalanine and its keto acid derivatives in neural cells: a possible pathomechanism and adjuvant therapy for brain injury in phenylketonuria.
    Faverzani JL; Steinmetz A; Deon M; Marchetti DP; Guerreiro G; Sitta A; de Moura Coelho D; Lopes FF; Nascimento LVM; Steffens L; Henn JG; Ferro MB; Brito VB; Wajner M; Moura DJ; Vargas CR
    Metab Brain Dis; 2021 Oct; 36(7):1957-1968. PubMed ID: 34216350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary biomarkers of oxidative stress and plasmatic inflammatory profile in phenylketonuric treated patients.
    Deon M; Sitta A; Faverzani JL; Guerreiro GB; Donida B; Marchetti DP; Mescka CP; Ribas GS; Coitinho AS; Wajner M; Vargas CR
    Int J Dev Neurosci; 2015 Dec; 47(Pt B):259-65. PubMed ID: 26456498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased peripheral of brain-derived neurotrophic factor levels in phenylketonuric patients treated with l-carnitine.
    Faverzani JL; Guerreiro G; Hammerschmidt TG; Lopes FF; Coelho DM; Sitta A; Mescka CP; Deon M; Wajner M; Vargas CR
    Arch Biochem Biophys; 2023 Nov; 749():109792. PubMed ID: 37863349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased cytokine levels induced by high phenylalanine concentrations in late diagnosis PKU patients compared to early diagnosis: Anti-inflammatory effect of L-carnitine.
    Faverzani JL; Hammerschmidt TG; Mescka CP; Guerreiro G; Lopes FF; Delgado CA; de Moura Coelho D; Sitta A; Deon M; Wajner M; Vargas CR
    Cell Biochem Funct; 2023 Jun; 41(4):490-500. PubMed ID: 37170672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that L-carnitine and selenium supplementation reduces oxidative stress in phenylketonuric patients.
    Sitta A; Vanzin CS; Biancini GB; Manfredini V; de Oliveira AB; Wayhs CA; Ribas GO; Giugliani L; Schwartz IV; Bohrer D; Garcia SC; Wajner M; Vargas CR
    Cell Mol Neurobiol; 2011 Apr; 31(3):429-36. PubMed ID: 21191647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of L-carnitine on Phenylalanine-induced DNA damage.
    Deon M; Landgraf SS; Lamberty JF; Moura DJ; Saffi J; Wajner M; Vargas CR
    Metab Brain Dis; 2015 Aug; 30(4):925-33. PubMed ID: 25600689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental evidence that phenylalanine provokes oxidative stress in hippocampus and cerebral cortex of developing rats.
    Fernandes CG; Leipnitz G; Seminotti B; Amaral AU; Zanatta A; Vargas CR; Dutra Filho CS; Wajner M
    Cell Mol Neurobiol; 2010 Mar; 30(2):317-26. PubMed ID: 19774456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of catalase and superoxide dismutase activities on oxidative stress in the brain of a phenylketonuria animal model and the effect of lipoic acid.
    Moraes TB; Jacques CE; Rosa AP; Dalazen GR; Terra M; Coelho JG; Dutra-Filho CS
    Cell Mol Neurobiol; 2013 Mar; 33(2):253-60. PubMed ID: 23232760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that DNA damage is associated to phenylalanine blood levels in leukocytes from phenylketonuric patients.
    Sitta A; Manfredini V; Biasi L; Treméa R; Schwartz IV; Wajner M; Vargas CR
    Mutat Res; 2009; 679(1-2):13-6. PubMed ID: 19665577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-carnitine blood levels and oxidative stress in treated phenylketonuric patients.
    Sitta A; Barschak AG; Deon M; de Mari JF; Barden AT; Vanzin CS; Biancini GB; Schwartz IV; Wajner M; Vargas CR
    Cell Mol Neurobiol; 2009 Mar; 29(2):211-8. PubMed ID: 18814025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of phenyllactate, phenylacetate, and phenylpyruvate by negative ion chemical ionization-gas chromatography/mass spectrometry in brain of mouse genetic models of phenylketonuria and non-phenylketonuria hyperphenylalaninemia.
    Sarkissian CN; Scriver CR; Mamer OA
    Anal Biochem; 2000 May; 280(2):242-9. PubMed ID: 10790306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenylalanine and its metabolites induce embryopathies in mouse embryos in culture.
    Denno KM; Sadler TW
    Teratology; 1990 Nov; 42(5):565-70. PubMed ID: 2278031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoic acid prevents oxidative stress in vitro and in vivo by an acute hyperphenylalaninemia chemically-induced in rat brain.
    Moraes TB; Zanin F; da Rosa A; de Oliveira A; Coelho J; Petrillo F; Wajner M; Dutra-Filho CS
    J Neurol Sci; 2010 May; 292(1-2):89-95. PubMed ID: 20226470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired glutamatergic synaptic transmission in the PKU brain.
    Martynyuk AE; Glushakov AV; Sumners C; Laipis PJ; Dennis DM; Seubert CN
    Mol Genet Metab; 2005 Dec; 86 Suppl 1():S34-42. PubMed ID: 16153867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the experimental phenylketonuria in rats.
    Iijima S; Ishii A; Miyakoshi T; Odaira T; Musha M
    Tohoku J Exp Med; 1975 Oct; 117(2):167-78. PubMed ID: 1209606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress in phenylketonuria: what is the evidence?
    Ribas GS; Sitta A; Wajner M; Vargas CR
    Cell Mol Neurobiol; 2011 Jul; 31(5):653-62. PubMed ID: 21516352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-carnitine supplementation as a potential antioxidant therapy for inherited neurometabolic disorders.
    Ribas GS; Vargas CR; Wajner M
    Gene; 2014 Jan; 533(2):469-76. PubMed ID: 24148561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma metabolomic profile changes in females with phenylketonuria following a camp intervention.
    Schoen MS; Singh RH
    Am J Clin Nutr; 2022 Mar; 115(3):811-821. PubMed ID: 34864852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Creatine plus pyruvate supplementation prevents oxidative stress and phosphotransfer network disturbances in the brain of rats subjected to chemically-induced phenylketonuria.
    Bortoluzzi VT; Brust L; Preissler T; de Franceschi ID; Wannmacher CMD
    Metab Brain Dis; 2019 Dec; 34(6):1649-1660. PubMed ID: 31352540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studying the effect of large neutral amino acid supplements on oxidative stress in phenylketonuric patients.
    Kumru B; Ozturk Hismi B; Kaplan DS; Celik H
    J Pediatr Endocrinol Metab; 2019 Mar; 32(3):269-274. PubMed ID: 30835252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.